CNBI Stock Overview
China BCT Pharmacy Group, Inc., through its subsidiaries, operates as an integrated pharmaceutical company in the People’s Republic of China.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
China BCT Pharmacy Group, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0001 |
| 52 Week High | US$0.0001 |
| 52 Week Low | US$0.0001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -98.99% |
| 5 Year Change | -96.97% |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| CNBI | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | 6.5% | -3.2% |
| 1Y | n/a | 4.0% | 19.3% |
Return vs Industry: Insufficient data to determine how CNBI performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how CNBI performed against the US Market.
Price Volatility
| CNBI volatility | |
|---|---|
| CNBI Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 6.9% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: CNBI has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine CNBI's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1956 | n/a | Huitian Tang | n/a |
China BCT Pharmacy Group, Inc., through its subsidiaries, operates as an integrated pharmaceutical company in the People’s Republic of China. It operates through three segments: Pharmaceutical Distribution, Retail Pharmacy, and Manufacturing Pharmacy. The Pharmaceutical Distribution segment purchases pharmaceutical products from suppliers and distributes them to hospitals, retail drug stores, other pharmaceutical wholesalers, clinics, medical centers, and individuals.
China BCT Pharmacy Group, Inc. Fundamentals Summary
| CNBI fundamental statistics | |
|---|---|
| Market cap | US$3.82k |
| Earnings (TTM) | US$11.50m |
| Revenue (TTM) | US$237.20m |
0.0x
P/E Ratio0.0x
P/S RatioIs CNBI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CNBI income statement (TTM) | |
|---|---|
| Revenue | US$237.20m |
| Cost of Revenue | US$193.78m |
| Gross Profit | US$43.42m |
| Other Expenses | US$31.92m |
| Earnings | US$11.50m |
Last Reported Earnings
Mar 31, 2013
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did CNBI perform over the long term?
See historical performance and comparison